Food and Drug Administration

Dermatologic and Ophthalmic Drugs Advisory Committee

September 9, 2003


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Briefing Document From Genetech, Inc. (HTM) (PDF) (Word)

Briefing Document From FDA (HTM) (PDF) (Word)

FDA's Efalizumab Briefing Book - Revisions to Text and Tables (PDF)